SARS-CoV-2 Assessment of Viral Evolution Publications

Davis-Gardner ME et al. Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster. NEJM, 2022 December 

Wang Q et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell, 2022 December 

Kurhade C et al. Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nature Medicine, 2022 December 

A Mykytyn et al. Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct. Science Immunology, 2022 June

P Halfmann et al. Characterization of the SARS-CoV-2 B.1.621 (Mu) variant. Science Translational Medicine, 2022 May

R Uraki et al. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2. Nature, 2022 May

E Takashita et al. Efficacy of Antiviral Agents Against the SARS-CoV-2 Omicron Subvariant BA.2. NEJM, April 2022

M DeGrace et al. Defining the risk of SARS-CoV-2 variants on immune protection. Nature, 2022 March

S Iketani et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022 March

V-V Edara et almRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantCell Reports Medicine. 2022 Feb

J Zou et alNeutralization against Omicron SARS-CoV-2 from previous non-Omicron infection. Nature Communications. 2022 Feb

K Hui et alSARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivoNature. 2022 Feb

E Takashita et al. Efficacy of antibodies and antiviral drugs against COVID-19 Omicron variant. NEJM. 2022 Jan

P Halfmann et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature. 2022 Jan

LA VanBlargan et al. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodies. Nature. 2022 Jan

MS Suthar et al. Durability of immune responses to the BNT162b2 mRNA vaccine. Cell. 2022 Jan 

M Gagne et al. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway. Cell. 2022 Jan

L Liu et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature. 2021 Dec

JM Carreno et al. Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate. Nature. 2021 Dec

NA Doria-Rose et al. Booster of mRNA-1273 Vaccine Reduces SARS-CoV-2 Omicron Escape from Neutralizing Antibodies. medRxiv. 2021 Dec  

B Ying et al. Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains. Sci Transl Med2021 Nov

V-V Edara et alInfection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantNEJM. 2021 Aug

Content last reviewed on